Kevin J Rome, José R Mediavilla, Austin J Terlecky, Mia J Bucich, Elena Shashkina, Jianping Jiang, Dillon Kunkle, Albert Rojtman, Eric Skaar, Liang Chen and 1 more
Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Kevin J RomeCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.ORCID 0000-0002-2262-4813
José R MediavillaCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
Austin J TerleckyCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
Mia J BucichCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
Elena ShashkinaCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
Jianping JiangCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
Dillon KunkleVanderbilt Institute for Infection, Immunology, and Inflammation, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Albert RojtmanCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.
Eric SkaarVanderbilt Institute for Infection, Immunology, and Inflammation, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0001-5094-8105
Liang ChenSchool of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York, USA.ORCID 0000-0001-5845-2235
Barry N KreiswithCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.ORCID 0000-0002-0243-131X
Funding
Host-mediated zinc sequestration during Acinetobacter baumannii infectionR01AI101171 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WALTER J. CHAZIN, DAVID P. GIEDROC · 2013 to 2026
$8.2M
NIH HHS R01AI101171
6 · The paper itself
Abstract
Cefiderocol (CFDC) is a siderophore-conjugated cephalosporin that hijacks bacterial iron uptake pathways to traverse the outer membrane, offering potent activity against carbapenem-resistant
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Genetic basis of cefiderocol resistance in · full record | OpenQuestion